Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (91-100 of 145) with videos related to

Pageof 15
Sort By:
Vaccine|August 19, 2014
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling studyJean-François Laprise, Mélanie Drolet, Marie-Claude Boily, et al.
Vaccine|January 31, 2012
Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective studyMélanie Drolet, Myron J Levin, Kenneth E Schmader, et al.
Lancet Regional Health. Americas|January 26, 2026
Single-dose HPV vaccination in the United States - a multi-modeling analysisEmily A Burger, Jean-François Laprise, Jennifer C Spencer, et al.
Lancet (London, England)|May 3, 2026
Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling studyMarc Brisson, Mélanie Drolet, Guillaume Gingras, et al.
Sexually Transmitted Diseases|January 25, 2021
Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United StatesRayleen M Lewis, Jean-François Laprise, Julia W Gargano, et al.
International Journal of Cancer|February 27, 2016
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: VaccinesJulia M L Brotherton, Mark Jit, Patti E Gravitt, et al.
European Journal of Pain (London, England)|May 24, 2011
Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resourcesAtika Benbernou, Mélanie Drolet, Myron J Levin, et al.
The Lancet. Infectious Diseases|July 10, 2021
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysisMélanie Drolet, Jean-François Laprise, Dave Martin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 27, 2022
Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): a population-based cohort study of the first three epidemic wavesYiqing Xia, Huiting Ma, David L Buckeridge, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden settingEmily A Burger, Jean-François Laprise, Allison Portnoy, et al.
Pageof 15

Showing results (91-100 of 145) with videos related to

Sort By:
Pageof 15
Vaccine|August 19, 2014
Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling studyJean-François Laprise, Mélanie Drolet, Marie-Claude Boily, et al.
Vaccine|January 31, 2012
Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective studyMélanie Drolet, Myron J Levin, Kenneth E Schmader, et al.
Lancet Regional Health. Americas|January 26, 2026
Single-dose HPV vaccination in the United States - a multi-modeling analysisEmily A Burger, Jean-François Laprise, Jennifer C Spencer, et al.
Lancet (London, England)|May 3, 2026
Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling studyMarc Brisson, Mélanie Drolet, Guillaume Gingras, et al.
Sexually Transmitted Diseases|January 25, 2021
Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United StatesRayleen M Lewis, Jean-François Laprise, Julia W Gargano, et al.
International Journal of Cancer|February 27, 2016
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: VaccinesJulia M L Brotherton, Mark Jit, Patti E Gravitt, et al.
European Journal of Pain (London, England)|May 24, 2011
Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resourcesAtika Benbernou, Mélanie Drolet, Myron J Levin, et al.
The Lancet. Infectious Diseases|July 10, 2021
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysisMélanie Drolet, Jean-François Laprise, Dave Martin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 27, 2022
Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): a population-based cohort study of the first three epidemic wavesYiqing Xia, Huiting Ma, David L Buckeridge, et al.
Journal of the National Cancer Institute. Monographs|November 12, 2024
Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden settingEmily A Burger, Jean-François Laprise, Allison Portnoy, et al.
Pageof 15